NeOnc Charting New Nasal Route to Treating Brain Cancer

GlobeNewswire Inc. | Sep 21, 2026 8:00 AM EDT

NeOnc's (NASDAQ: NTHI) NEO100 is testing a different answer to one of brain cancer’s oldest problems.